CBX5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.249640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.831200E-01
Normal-vs-Stage2
5.071600E-02
Normal-vs-Stage3
3.077000E-03
Normal-vs-Stage4
1.182410E-01
Stage1-vs-Stage2
1.123030E-01
Stage1-vs-Stage3
1.372470E-02
Stage1-vs-Stage4
2.532400E-01
Stage2-vs-Stage3
6.215800E-02
Stage2-vs-Stage4
8.378800E-01
Stage3-vs-Stage4
1.383250E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.467440E-01
Normal-vs-AfricanAmerican
2.693600E-01
Normal-vs-Asian
6.796000E-03
Caucasian-vs-AfricanAmerican
5.654200E-01
Caucasian-vs-Asian
4.954200E-02
AfricanAmerican-vs-Asian
3.437600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.697040E-01
Normal-vs-Female
8.700200E-02
Male-vs-Female
7.496600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.813400E-01
Normal-vs-Age(41-60Yrs)
3.426200E-01
Normal-vs-Age(61-80Yrs)
7.593800E-02
Normal-vs-Age(81-100Yrs)
9.779700E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.008600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.566600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.485160E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.535900E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.584100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.247800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.012300E-02
Normal-vs-Daily Drinker
8.341700E-02
Normal-vs-Weekly Drinker
1.915920E-02
Normal-vs-Occasional Drinker
1.999820E-01
Normal-vs-Social Drinker
5.592800E-01
Non Drinker-vs-Daily Drinker
9.877200E-01
Non Drinker-vs-Weekly Drinker
8.825200E-01
Non Drinker-vs-Occasional Drinker
4.012100E-02
Non Drinker-vs-Social Drinker
8.020400E-02
Daily Drinker-vs-Weekly Drinker
9.269000E-01
Daily Drinker-vs-Occasional Drinker
1.274600E-01
Daily Drinker-vs-Social Drinker
9.269900E-02
Weekly Drinker-vs-Occasional Drinker
7.898400E-02
Weekly Drinker-vs-Social Drinker
8.429600E-02
Occasional Drinker-vs-Social Drinker
6.003800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.971200E-01
Normal-vs-Grade 2
8.384200E-01
Normal-vs-Grade 3
8.000800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.488100E-02
Grade 1-vs-Grade 3
9.709700E-02
Grade 1-vs-Grade 4
3.971200E-01
Grade 2-vs-Grade 3
4.743600E-01
Grade 2-vs-Grade 4
8.384200E-01
Grade 3-vs-Grade 4
8.000800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.322250E-02
Normal-vs-NonDiabetic
1.587760E-01
Diabetic-vs-NonDiabetic
1.169570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.763800E-03
Normal-vs-NoPancreatitis
1.065210E-01
Pancreatitis-vs-NoPancreatitis
3.060800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.891000E-01
Normal-vs-N1
6.251900E-02
N0-vs-N1
4.357000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.865700E-02
Normal-vs-TP53-NonMutant
6.020000E-01
TP53-Mutant-vs-TP53-NonMutant
2.290100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
